Sky Century Investment (SKYI) Notes Payables (2024 - 2026)

Sky Century Investment's (SKYI) quarterly Notes Payables came in at $180000.0 in Q2 2026, down 12.2% year-on-year from $205000.0 in Q2 2025, and down 28.0% on a QoQ basis from $250000.0 in Q1 2026.

Sky Century Investment (SKYI) Notes Payables (2024 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 3 years of Notes Payables data on file, last reported at $180000.0 in Q2 2026.

  • On a quarterly basis, Notes Payables fell 12.2% year-over-year to $180000.0 in Q2 2026; TTM through May 2026 was $180000.0, a 12.2% decrease from a year earlier, with the FY2025 full-year figure at $220000.0, up 37.5% from the prior year.
  • Notes Payables for Q2 2026 stood at $180000.0, down from $250000.0 in the prior quarter.
  • Over the last five years, Notes Payables for SKYI reached as high as $250000.0 in Q1 2026 and fell as low as $160000.0 in Q3 2024.
  • Historically, Notes Payables has averaged $205714.3 across 3 years, with a median of $205000.0 in 2025.
  • Across the five-year window, Notes Payables jumped 37.5% in 2025 and declined 12.2% in 2026, its largest moves.
  • Year by year, Notes Payables stood at $160000.0 in 2024, then jumped by 46.88% to $235000.0 in 2025, then slipped by 23.4% to $180000.0 in 2026.
  • Per Business Quant data, the three most recent Notes Payables figures were $180000.0 in Q2 2026, $250000.0 in Q1 2026, and $235000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00

Historic Data

Download Data
DateValue
May 31, 2026 180,000.00
Feb 28, 2026 250,000.00
Nov 30, 2025 235,000.00
Aug 31, 2025 220,000.00
May 31, 2025 205,000.00
Feb 28, 2025 190,000.00
Aug 31, 2024 160,000.00